| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.94e-05 | 188 | 98 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | transition metal ion binding | MORC1 ADCY10 MID2 TRIM34 TRIM21 TRIM6 TRIM22 TRIM5 TRIM10 TRAFD1 P3H1 MID1 RNF41 CYP4F3 CYP4F12 ZMYM6 | 2.10e-04 | 1189 | 98 | 16 | GO:0046914 |
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 2.36e-04 | 5 | 98 | 2 | GO:0052871 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 4.93e-04 | 7 | 98 | 2 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 4.93e-04 | 7 | 98 | 2 | GO:0018685 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 4.93e-04 | 372 | 98 | 8 | GO:0061630 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | 5.31e-04 | 473 | 98 | 9 | GO:0004842 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 6.14e-04 | 34 | 98 | 3 | GO:0017147 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | AMHR2 MID2 TRIM34 TRIM21 TRIM6 TRIM22 TRIM5 TGFB2 MID1 IZUMO1 PRMT2 TP53BP2 | 6.39e-04 | 815 | 98 | 12 | GO:0042803 |
| GeneOntologyMolecularFunction | protein dimerization activity | AMHR2 MID2 TRIM34 TRIM21 HIF3A TRIM6 TRIM22 TRIM5 TGFB2 MID1 IZUMO1 PRMT2 FZD2 SLC4A11 TP53BP2 | 7.62e-04 | 1205 | 98 | 15 | GO:0046983 |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 7.66e-04 | 398 | 98 | 8 | GO:0061659 | |
| GeneOntologyMolecularFunction | kinase binding | TPCN2 TRIM34 TRIM21 RB1CC1 TRIM6 TRIM22 SH2B2 TRIM5 RBCK1 PER3 STRADA RNF41 MUSK | 8.95e-04 | 969 | 98 | 13 | GO:0019900 |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 9.31e-04 | 512 | 98 | 9 | GO:0019787 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 1.05e-03 | 10 | 98 | 2 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 1.05e-03 | 10 | 98 | 2 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 1.05e-03 | 10 | 98 | 2 | GO:0102033 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 1.22e-03 | 532 | 98 | 9 | GO:0016755 | |
| GeneOntologyMolecularFunction | zinc ion binding | MORC1 MID2 TRIM34 TRIM21 TRIM6 TRIM22 TRIM5 TRIM10 TRAFD1 MID1 RNF41 ZMYM6 | 1.38e-03 | 891 | 98 | 12 | GO:0008270 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.49e-03 | 46 | 98 | 3 | GO:0030020 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.49e-03 | 46 | 98 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | glycosphingolipid binding | 1.80e-03 | 13 | 98 | 2 | GO:0043208 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 1.80e-03 | 13 | 98 | 2 | GO:0016713 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.13e-03 | 52 | 98 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 2.40e-03 | 15 | 98 | 2 | GO:0051011 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.73e-03 | 118 | 98 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 2.74e-03 | 16 | 98 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 3.09e-03 | 17 | 98 | 2 | GO:0042813 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 3.17e-03 | 123 | 98 | 4 | GO:0030165 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.47e-03 | 18 | 98 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 3.47e-03 | 18 | 98 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | protein kinase binding | TPCN2 TRIM34 TRIM21 RB1CC1 TRIM6 TRIM22 SH2B2 TRIM5 RBCK1 RNF41 MUSK | 3.66e-03 | 873 | 98 | 11 | GO:0019901 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 3.81e-03 | 303 | 98 | 6 | GO:0003713 | |
| GeneOntologyMolecularFunction | microtubule binding | 4.12e-03 | 308 | 98 | 6 | GO:0008017 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL6A2 EPPK1 VWF COL16A1 LAMA1 NUP88 SSPOP FBLN2 COL21A1 MACF1 EPB41L2 | 4.27e-03 | 891 | 98 | 11 | GO:0005198 |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 4.71e-03 | 21 | 98 | 2 | GO:0030228 | |
| GeneOntologyBiologicalProcess | regulation of viral entry into host cell | 6.89e-09 | 55 | 97 | 7 | GO:0046596 | |
| GeneOntologyBiologicalProcess | modulation by symbiont of entry into host | 1.63e-08 | 62 | 97 | 7 | GO:0052372 | |
| GeneOntologyBiologicalProcess | regulation of biological process involved in symbiotic interaction | 6.24e-08 | 75 | 97 | 7 | GO:0043903 | |
| GeneOntologyBiologicalProcess | regulation of autophagy | ADCY10 TPCN2 MID2 TRIM34 TRIM21 RB1CC1 TRIM6 TRIM22 TRIM5 MET VPS13D RNF41 | 3.88e-07 | 400 | 97 | 12 | GO:0010506 |
| GeneOntologyBiologicalProcess | symbiont entry into host cell | 1.34e-06 | 169 | 97 | 8 | GO:0046718 | |
| GeneOntologyBiologicalProcess | positive regulation of autophagy | 1.60e-06 | 173 | 97 | 8 | GO:0010508 | |
| GeneOntologyBiologicalProcess | symbiont entry into host | 1.81e-06 | 176 | 97 | 8 | GO:0044409 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-binding transcription factor activity | 3.93e-06 | 261 | 97 | 9 | GO:0051091 | |
| GeneOntologyBiologicalProcess | positive regulation of NF-kappaB transcription factor activity | 7.26e-06 | 151 | 97 | 7 | GO:0051092 | |
| GeneOntologyBiologicalProcess | protein polyubiquitination | 8.94e-06 | 289 | 97 | 9 | GO:0000209 | |
| GeneOntologyBiologicalProcess | regulation of viral life cycle | 8.99e-06 | 156 | 97 | 7 | GO:1903900 | |
| GeneOntologyBiologicalProcess | process utilizing autophagic mechanism | ADCY10 TPCN2 MID2 TRIM34 TRIM21 RB1CC1 TRIM6 TRIM22 TRIM5 MET VPS13D VPS41 RNF41 | 1.10e-05 | 650 | 97 | 13 | GO:0061919 |
| GeneOntologyBiologicalProcess | autophagy | ADCY10 TPCN2 MID2 TRIM34 TRIM21 RB1CC1 TRIM6 TRIM22 TRIM5 MET VPS13D VPS41 RNF41 | 1.10e-05 | 650 | 97 | 13 | GO:0006914 |
| GeneOntologyBiologicalProcess | biological process involved in interaction with host | 1.22e-05 | 228 | 97 | 8 | GO:0051701 | |
| GeneOntologyBiologicalProcess | regulation of viral process | 2.81e-05 | 186 | 97 | 7 | GO:0050792 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular signal transduction | SELP ADCY10 VWF MID2 TRIM34 TRIM21 RB1CC1 TRIM6 TRIM22 TRIM5 RBCK1 TGFB2 FZD7 MET EDARADD MID1 GPNMB MUSK | 3.11e-05 | 1299 | 97 | 18 | GO:1902533 |
| GeneOntologyBiologicalProcess | regulation of DNA-binding transcription factor activity | MID2 TRIM34 TRIM21 TRIM6 TRIM22 TRIM5 RBCK1 PRMT2 RNF41 FZD2 | 5.02e-05 | 449 | 97 | 10 | GO:0051090 |
| GeneOntologyBiologicalProcess | positive regulation of canonical NF-kappaB signal transduction | 6.64e-05 | 213 | 97 | 7 | GO:0043123 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | ADCY10 TPCN2 MID2 TRIM34 TRIM21 RB1CC1 TRIM6 PNPLA5 TRIM22 TRIM5 MET VPS13D VPS41 RNF41 CYP4F3 CYP4F12 DCXR | 6.94e-05 | 1253 | 97 | 17 | GO:0044248 |
| GeneOntologyBiologicalProcess | suppression of viral release by host | 7.82e-05 | 18 | 97 | 3 | GO:0044790 | |
| GeneOntologyBiologicalProcess | negative regulation of viral process | 1.26e-04 | 103 | 97 | 5 | GO:0048525 | |
| GeneOntologyBiologicalProcess | canonical NF-kappaB signal transduction | 1.66e-04 | 330 | 97 | 8 | GO:0007249 | |
| GeneOntologyBiologicalProcess | viral life cycle | 2.03e-04 | 340 | 97 | 8 | GO:0019058 | |
| GeneOntologyBiologicalProcess | biological process involved in symbiotic interaction | 2.52e-04 | 351 | 97 | 8 | GO:0044403 | |
| GeneOntologyBiologicalProcess | negative regulation of viral entry into host cell | 3.03e-04 | 28 | 97 | 3 | GO:0046597 | |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 3.24e-04 | 6 | 97 | 2 | GO:0036101 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | MID2 MYO9A DOCK8 ARRDC4 TRIM34 TRIM21 TRIM6 TRIM22 TRIM5 RBCK1 TGFB2 MET STRADA RNF41 RXFP1 FZD2 MUSK | 3.38e-04 | 1430 | 97 | 17 | GO:0044093 |
| GeneOntologyBiologicalProcess | morphogenesis of a polarized epithelium | 3.90e-04 | 73 | 97 | 4 | GO:0001738 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 4.53e-04 | 7 | 97 | 2 | GO:0036102 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-threonine phosphorylation | 4.53e-04 | 32 | 97 | 3 | GO:0010800 | |
| GeneOntologyBiologicalProcess | protein K63-linked ubiquitination | 4.55e-04 | 76 | 97 | 4 | GO:0070534 | |
| GeneOntologyBiologicalProcess | negative regulation of viral life cycle | 4.97e-04 | 33 | 97 | 3 | GO:1903901 | |
| GeneOntologyBiologicalProcess | regulation of canonical NF-kappaB signal transduction | 5.19e-04 | 298 | 97 | 7 | GO:0043122 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 6.02e-04 | 8 | 97 | 2 | GO:0036100 | |
| GeneOntologyBiologicalProcess | regulation of mitophagy | 7.55e-04 | 38 | 97 | 3 | GO:1901524 | |
| Domain | ConA-like_dom | COL16A1 MID2 LAMA1 TRIM34 TRIM21 TRIM6 TRIM22 TRIM5 RYR1 TRIM10 MALRD1 COL21A1 MID1 | 1.41e-10 | 219 | 99 | 13 | IPR013320 |
| Domain | ZF_BBOX | 3.88e-10 | 80 | 99 | 9 | PS50119 | |
| Domain | Znf_B-box | 4.34e-10 | 81 | 99 | 9 | IPR000315 | |
| Domain | SPRY | 8.32e-10 | 87 | 99 | 9 | SM00449 | |
| Domain | Znf_RING_CS | MKRN3 MID2 TRIM34 TRIM21 TRIM6 TRIM22 TRIM5 RBCK1 TRIM10 MID1 RNF41 | 1.04e-09 | 163 | 99 | 11 | IPR017907 |
| Domain | SPRY | 1.67e-09 | 94 | 99 | 9 | PF00622 | |
| Domain | SPRY_dom | 1.67e-09 | 94 | 99 | 9 | IPR003877 | |
| Domain | B30.2/SPRY | 1.84e-09 | 95 | 99 | 9 | IPR001870 | |
| Domain | B302_SPRY | 1.84e-09 | 95 | 99 | 9 | PS50188 | |
| Domain | BBOX | 3.00e-09 | 69 | 99 | 8 | SM00336 | |
| Domain | Butyrophylin | 3.37e-09 | 70 | 99 | 8 | IPR003879 | |
| Domain | - | 3.78e-09 | 71 | 99 | 8 | 4.10.45.10 | |
| Domain | zf-B_box | 4.23e-09 | 72 | 99 | 8 | PF00643 | |
| Domain | zf-RING_UBOX | 2.27e-08 | 34 | 99 | 6 | PF13445 | |
| Domain | Znf-RING_LisH | 2.27e-08 | 34 | 99 | 6 | IPR027370 | |
| Domain | Znf_C3HC4_RING-type | MKRN3 MID2 TRIM34 TRIM21 TRIM6 TRIM22 TRIM5 RBCK1 TRIM10 RNF41 | 2.60e-08 | 172 | 99 | 10 | IPR018957 |
| Domain | zf-C3HC4 | MKRN3 MID2 TRIM34 TRIM21 TRIM6 TRIM22 TRIM5 RBCK1 TRIM10 MID1 RNF41 | 2.76e-08 | 223 | 99 | 11 | PF00097 |
| Domain | ZF_RING_1 | MKRN3 MID2 TRIM34 TRIM21 TRIM6 TRIM22 TRIM5 RBCK1 TRIM10 MID1 VPS41 RNF41 | 4.51e-08 | 291 | 99 | 12 | PS00518 |
| Domain | ZF_RING_2 | MKRN3 MID2 TRIM34 TRIM21 TRIM6 TRIM22 TRIM5 RBCK1 TRIM10 MID1 VPS41 RNF41 | 5.86e-08 | 298 | 99 | 12 | PS50089 |
| Domain | RING | MKRN3 MID2 TRIM34 TRIM21 TRIM6 TRIM22 TRIM5 RBCK1 TRIM10 MID1 VPS41 RNF41 | 7.54e-08 | 305 | 99 | 12 | SM00184 |
| Domain | Znf_RING | MKRN3 MID2 TRIM34 TRIM21 TRIM6 TRIM22 TRIM5 RBCK1 TRIM10 MID1 VPS41 RNF41 | 1.55e-07 | 326 | 99 | 12 | IPR001841 |
| Domain | - | MKRN3 MID2 TRIM34 TRIM21 TRIM6 TRIM22 TRIM5 RBCK1 TRIM10 MID1 VPS41 RNF41 | 4.49e-06 | 449 | 99 | 12 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | MKRN3 MID2 TRIM34 TRIM21 TRIM6 TRIM22 TRIM5 RBCK1 TRIM10 MID1 VPS41 RNF41 | 5.62e-06 | 459 | 99 | 12 | IPR013083 |
| Domain | LDLR_class-A_CS | 5.86e-05 | 40 | 99 | 4 | IPR023415 | |
| Domain | Ldl_recept_a | 9.37e-05 | 45 | 99 | 4 | PF00057 | |
| Domain | - | 1.02e-04 | 46 | 99 | 4 | 4.10.400.10 | |
| Domain | PRY | 1.21e-04 | 48 | 99 | 4 | SM00589 | |
| Domain | LDLRA_1 | 1.21e-04 | 48 | 99 | 4 | PS01209 | |
| Domain | PRY | 1.21e-04 | 48 | 99 | 4 | IPR006574 | |
| Domain | LDrepeatLR_classA_rpt | 1.31e-04 | 49 | 99 | 4 | IPR002172 | |
| Domain | LDLa | 1.31e-04 | 49 | 99 | 4 | SM00192 | |
| Domain | LDLRA_2 | 1.31e-04 | 49 | 99 | 4 | PS50068 | |
| Domain | - | 1.79e-04 | 21 | 99 | 3 | 1.10.2000.10 | |
| Domain | VWA | 2.21e-04 | 56 | 99 | 4 | PF00092 | |
| Domain | Frizzled_dom | 2.70e-04 | 24 | 99 | 3 | IPR020067 | |
| Domain | FZ | 2.70e-04 | 24 | 99 | 3 | PS50038 | |
| Domain | Fz | 2.70e-04 | 24 | 99 | 3 | PF01392 | |
| Domain | - | 4.11e-04 | 6 | 99 | 2 | 3.90.1290.10 | |
| Domain | EGF_1 | 4.17e-04 | 255 | 99 | 7 | PS00022 | |
| Domain | EGF_2 | 5.24e-04 | 265 | 99 | 7 | PS01186 | |
| Domain | Plectin | 5.74e-04 | 7 | 99 | 2 | PF00681 | |
| Domain | Plectin_repeat | 5.74e-04 | 7 | 99 | 2 | IPR001101 | |
| Domain | PLEC | 5.74e-04 | 7 | 99 | 2 | SM00250 | |
| Domain | - | 6.43e-04 | 74 | 99 | 4 | 3.40.50.410 | |
| Domain | DHC_N1 | 7.63e-04 | 8 | 99 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 7.63e-04 | 8 | 99 | 2 | IPR013594 | |
| Domain | VWFA | 9.47e-04 | 82 | 99 | 4 | PS50234 | |
| Domain | DUF1220 | 9.77e-04 | 9 | 99 | 2 | SM01148 | |
| Domain | VWA | 1.04e-03 | 84 | 99 | 4 | SM00327 | |
| Domain | IQ_motif_EF-hand-BS | 1.34e-03 | 90 | 99 | 4 | IPR000048 | |
| Domain | PRY | 1.43e-03 | 42 | 99 | 3 | PF13765 | |
| Domain | Frizzled | 1.48e-03 | 11 | 99 | 2 | IPR000539 | |
| Domain | Frizzled | 1.48e-03 | 11 | 99 | 2 | PF01534 | |
| Domain | DUF1220 | 1.48e-03 | 11 | 99 | 2 | PF06758 | |
| Domain | NBPF_dom | 1.48e-03 | 11 | 99 | 2 | IPR010630 | |
| Domain | NBPF | 1.48e-03 | 11 | 99 | 2 | PS51316 | |
| Domain | Frizzled | 1.48e-03 | 11 | 99 | 2 | SM01330 | |
| Domain | IQ | 1.51e-03 | 93 | 99 | 4 | PS50096 | |
| Domain | EGF | 1.58e-03 | 235 | 99 | 6 | SM00181 | |
| Domain | EGF_3 | 1.58e-03 | 235 | 99 | 6 | PS50026 | |
| Domain | COS | 1.77e-03 | 12 | 99 | 2 | PS51262 | |
| Domain | C8 | 1.77e-03 | 12 | 99 | 2 | PF08742 | |
| Domain | TIL | 1.77e-03 | 12 | 99 | 2 | PF01826 | |
| Domain | COS_domain | 1.77e-03 | 12 | 99 | 2 | IPR017903 | |
| Domain | VWF_A | 1.90e-03 | 99 | 99 | 4 | IPR002035 | |
| Domain | Unchr_dom_Cys-rich | 2.09e-03 | 13 | 99 | 2 | IPR014853 | |
| Domain | C8 | 2.09e-03 | 13 | 99 | 2 | SM00832 | |
| Domain | EGF-like_dom | 2.11e-03 | 249 | 99 | 6 | IPR000742 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.43e-03 | 14 | 99 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.43e-03 | 14 | 99 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.43e-03 | 14 | 99 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.43e-03 | 14 | 99 | 2 | PF08393 | |
| Domain | TIL_dom | 2.43e-03 | 14 | 99 | 2 | IPR002919 | |
| Domain | ATPase_dyneun-rel_AAA | 2.43e-03 | 14 | 99 | 2 | IPR011704 | |
| Domain | MT | 2.43e-03 | 14 | 99 | 2 | PF12777 | |
| Domain | AAA_8 | 2.43e-03 | 14 | 99 | 2 | PF12780 | |
| Domain | AAA_5 | 2.43e-03 | 14 | 99 | 2 | PF07728 | |
| Domain | EGF-like_CS | 2.67e-03 | 261 | 99 | 6 | IPR013032 | |
| Domain | DHC_fam | 2.79e-03 | 15 | 99 | 2 | IPR026983 | |
| Domain | Bbox_C | 2.79e-03 | 15 | 99 | 2 | IPR003649 | |
| Domain | BBC | 2.79e-03 | 15 | 99 | 2 | SM00502 | |
| Domain | Dynein_heavy | 2.79e-03 | 15 | 99 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.79e-03 | 15 | 99 | 2 | IPR004273 | |
| Domain | Ubiquitin-rel_dom | 2.98e-03 | 184 | 99 | 5 | IPR029071 | |
| Domain | VWF_type-D | 3.18e-03 | 16 | 99 | 2 | IPR001846 | |
| Domain | VWFD | 3.18e-03 | 16 | 99 | 2 | PS51233 | |
| Domain | SIAH-type | 3.18e-03 | 16 | 99 | 2 | IPR013323 | |
| Domain | VWD | 3.18e-03 | 16 | 99 | 2 | SM00216 | |
| Domain | VWD | 3.18e-03 | 16 | 99 | 2 | PF00094 | |
| Domain | Frizzled/SFRP | 3.18e-03 | 16 | 99 | 2 | IPR015526 | |
| Domain | Laminin_G | 3.61e-03 | 58 | 99 | 3 | IPR001791 | |
| Domain | CTCK_1 | 4.03e-03 | 18 | 99 | 2 | PS01185 | |
| Domain | VWC_out | 4.48e-03 | 19 | 99 | 2 | SM00215 | |
| Domain | EGF | 4.54e-03 | 126 | 99 | 4 | PF00008 | |
| Domain | FRI | 4.97e-03 | 20 | 99 | 2 | SM00063 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 1.12e-06 | 98 | 78 | 7 | M965 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL6A2 VWF COL16A1 LAMA1 TGFB2 FBLN2 COL21A1 P3H1 ADAMTS18 MUSK | 5.75e-06 | 300 | 78 | 10 | M610 |
| Pathway | REACTOME_INTERFERON_SIGNALING | 1.30e-04 | 273 | 78 | 8 | M983 | |
| Pubmed | 3.37e-13 | 41 | 101 | 8 | 11331580 | ||
| Pubmed | Unique features of TRIM5alpha among closely related human TRIM family members. | 3.91e-12 | 7 | 101 | 5 | 17156811 | |
| Pubmed | Antiretroviral potential of human tripartite motif-5 and related proteins. | 6.70e-11 | 4 | 101 | 4 | 16828831 | |
| Pubmed | 1.00e-09 | 6 | 101 | 4 | 16775307 | ||
| Pubmed | 1.55e-09 | 18 | 101 | 5 | 23077300 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 21264255 | ||
| Pubmed | 2.54e-08 | 105 | 101 | 7 | 22493164 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 19147168 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 21680743 | ||
| Pubmed | TRIM E3 ligases interfere with early and late stages of the retroviral life cycle. | 3.86e-07 | 21 | 101 | 4 | 18248090 | |
| Pubmed | TRIM27 negatively regulates NOD2 by ubiquitination and proteasomal degradation. | 1.97e-06 | 9 | 101 | 3 | 22829933 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 2.64e-06 | 208 | 101 | 7 | 33230847 | |
| Pubmed | Essential roles of mesenchyme-derived beta-catenin in mouse Müllerian duct morphogenesis. | 2.81e-06 | 10 | 101 | 3 | 17532316 | |
| Pubmed | Analysis of the human E2 ubiquitin conjugating enzyme protein interaction network. | 5.07e-06 | 149 | 101 | 6 | 19549727 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23991205 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 27590274 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19943174 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 24314652 | ||
| Pubmed | Trim5alpha protein restricts both HIV-1 and murine leukemia virus. | 8.35e-06 | 2 | 101 | 2 | 15249690 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 18802014 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 24014239 | ||
| Pubmed | Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals. | 8.35e-06 | 2 | 101 | 2 | 18159944 | |
| Pubmed | Expression and physiological function of CYP4F subfamily in human eosinophils. | 8.35e-06 | 2 | 101 | 2 | 17980168 | |
| Pubmed | Mid1/Mid2 expression in craniofacial development and a literature review of X-linked opitz syndrome. | 8.35e-06 | 2 | 101 | 2 | 26788540 | |
| Pubmed | TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment. | 8.35e-06 | 2 | 101 | 2 | 24478420 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 21933672 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 20716766 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 26962963 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 24008159 | ||
| Pubmed | TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner. | 8.35e-06 | 2 | 101 | 2 | 32282853 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 38355315 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 14630802 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 8.38e-06 | 248 | 101 | 7 | 24006456 | |
| Pubmed | Structural and functional insights into the B30.2/SPRY domain. | 8.45e-06 | 14 | 101 | 3 | 16498413 | |
| Pubmed | The characterization of mice with a targeted combined deficiency of protein c and factor XI. | 1.05e-05 | 15 | 101 | 3 | 11159184 | |
| Pubmed | 1.27e-05 | 175 | 101 | 6 | 28071719 | ||
| Pubmed | 1.57e-05 | 17 | 101 | 3 | 24850809 | ||
| Pubmed | TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity. | 2.23e-05 | 19 | 101 | 3 | 26347139 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 9813155 | ||
| Pubmed | Mapping of susceptibility loci for Ebola virus pathogenesis in mice. | 2.50e-05 | 3 | 101 | 2 | 38652660 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 11013086 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 17849054 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 29077161 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 17996853 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 20001730 | ||
| Pubmed | Fibulin-2 binds to the short arms of laminin-5 and laminin-1 via conserved amino acid sequences. | 2.50e-05 | 3 | 101 | 2 | 9006922 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 25390649 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 17275499 | ||
| Pubmed | A conserved fertilization complex bridges sperm and egg in vertebrates. | 2.50e-05 | 3 | 101 | 2 | 39423812 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 22100896 | ||
| Pubmed | Endothelial cell markers in patients with pseudoexfoliation syndrome. | 2.50e-05 | 3 | 101 | 2 | 22593709 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 28028151 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 11806752 | ||
| Pubmed | Frizzled proteins are colonic epithelial receptors for C. difficile toxin B. | 2.50e-05 | 3 | 101 | 2 | 27680706 | |
| Pubmed | Restriction genes for retroviruses influence the risk of multiple sclerosis. | 2.50e-05 | 3 | 101 | 2 | 24066097 | |
| Pubmed | Expression of P-selectin, von Willebrand and endothelin-1 after carotid artery stenting. | 2.50e-05 | 3 | 101 | 2 | 21638248 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 27943541 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 10934193 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 12036879 | ||
| Pubmed | TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition. | 2.61e-05 | 20 | 101 | 3 | 25127057 | |
| Pubmed | 3.50e-05 | 63 | 101 | 4 | 23105109 | ||
| Pubmed | 3.72e-05 | 64 | 101 | 4 | 22261194 | ||
| Pubmed | CFTR interactome mapping using the mammalian membrane two-hybrid high-throughput screening system. | 4.46e-05 | 440 | 101 | 8 | 35156780 | |
| Pubmed | 4.60e-05 | 24 | 101 | 3 | 27693506 | ||
| Pubmed | Evolutionarily conserved sperm factors, DCST1 and DCST2, are required for gamete fusion. | 4.99e-05 | 4 | 101 | 2 | 33871360 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 15536090 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 36140829 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 11685209 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 11071623 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 15956287 | ||
| Pubmed | Ror2 modulates the canonical Wnt signaling in lung epithelial cells through cooperation with Fzd2. | 4.99e-05 | 4 | 101 | 2 | 18215320 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 18761340 | ||
| Pubmed | Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. | 4.99e-05 | 4 | 101 | 2 | 18065749 | |
| Pubmed | Factors associated with early platelet activation in obese children. | 4.99e-05 | 4 | 101 | 2 | 24415745 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | EDC3 MYO19 LAMA1 CKAP5 SSPOP RYR1 P3H1 RXFP1 SLC26A11 EPB41L2 | 5.77e-05 | 736 | 101 | 10 | 29676528 |
| Pubmed | Functional interactions between ubiquitin E2 enzymes and TRIM proteins. | 6.61e-05 | 27 | 101 | 3 | 21143188 | |
| Pubmed | 7.39e-05 | 28 | 101 | 3 | 35474067 | ||
| Pubmed | Sperm IZUMO1 Is Required for Binding Preceding Fusion With Oolemma in Mice and Rats. | 8.30e-05 | 5 | 101 | 2 | 35096839 | |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 26909801 | ||
| Pubmed | Defective vascular development in connexin 45-deficient mice. | 8.30e-05 | 5 | 101 | 2 | 10976050 | |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 18256319 | ||
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 7851641 | ||
| Pubmed | 8.70e-05 | 153 | 101 | 5 | 25037231 | ||
| Pubmed | MKRN3 CFH VWF CKAP5 FUZ SMG5 LRP1B TRIM5 RBCK1 STAB1 PRMT2 MACF1 WDR13 | 9.00e-05 | 1285 | 101 | 13 | 35914814 | |
| Pubmed | MKRN3 EDC3 DOCK8 LRCH1 TRIM10 FZD7 UBXN11 TRAFD1 EDARADD MID1 RNF41 DCXR MVK TP53BP2 | 9.45e-05 | 1477 | 101 | 14 | 31515488 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 1.19e-04 | 86 | 101 | 4 | 28327460 | |
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 19332769 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 1.24e-04 | 6 | 101 | 2 | 26025922 | |
| Pubmed | Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling. | 1.24e-04 | 6 | 101 | 2 | 20802536 | |
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 36867021 | ||
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 9068972 | ||
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 33347437 | ||
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 16434393 | ||
| Pubmed | 1.31e-04 | 167 | 101 | 5 | 22159717 | ||
| Pubmed | Human immunodeficiency virus, restriction factors, and interferon. | 1.74e-04 | 7 | 101 | 2 | 19694548 | |
| Pubmed | 1.74e-04 | 7 | 101 | 2 | 29949772 | ||
| Pubmed | 1.74e-04 | 7 | 101 | 2 | 8950511 | ||
| Pubmed | 1.74e-04 | 7 | 101 | 2 | 31178125 | ||
| Pubmed | 1.77e-04 | 402 | 101 | 7 | 24722188 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | EDC3 MYO9A CKAP5 VPS13D MACF1 MPHOSPH9 PLCH1 MUSK EPB41L2 TP53BP2 | 2.07e-04 | 861 | 101 | 10 | 36931259 |
| Interaction | TRIM5 interactions | 3.00e-07 | 91 | 98 | 7 | int:TRIM5 | |
| Interaction | UBE2U interactions | 3.90e-07 | 139 | 98 | 8 | int:UBE2U | |
| Interaction | UBE2K interactions | 6.63e-07 | 149 | 98 | 8 | int:UBE2K | |
| Interaction | TRIM34 interactions | 1.19e-06 | 17 | 98 | 4 | int:TRIM34 | |
| Interaction | OTUB2 interactions | 7.38e-06 | 96 | 98 | 6 | int:OTUB2 | |
| Interaction | UBE2D1 interactions | 1.34e-05 | 294 | 98 | 9 | int:UBE2D1 | |
| Interaction | UBE2D4 interactions | 2.52e-05 | 119 | 98 | 6 | int:UBE2D4 | |
| Interaction | UBE2N interactions | 5.37e-05 | 351 | 98 | 9 | int:UBE2N | |
| Interaction | UBE2D3 interactions | 7.23e-05 | 283 | 98 | 8 | int:UBE2D3 | |
| Cytoband | 11p15 | 1.20e-04 | 43 | 101 | 3 | 11p15 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 3.49e-09 | 95 | 71 | 8 | 59 | |
| GeneFamily | Ring finger proteins | MKRN3 MID2 TRIM34 TRIM21 TRIM6 TRIM22 TRIM5 RBCK1 TRIM10 MID1 RNF41 | 9.43e-09 | 275 | 71 | 11 | 58 |
| GeneFamily | EF-hand domain containing|Plakins | 4.19e-04 | 8 | 71 | 2 | 939 | |
| GeneFamily | Collagens | 7.80e-04 | 46 | 71 | 3 | 490 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 8.17e-04 | 11 | 71 | 2 | 286 | |
| GeneFamily | Dyneins, axonemal | 1.99e-03 | 17 | 71 | 2 | 536 | |
| GeneFamily | Neuroblastoma breakpoint family | 3.65e-03 | 23 | 71 | 2 | 662 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 5.01e-03 | 27 | 71 | 2 | 1253 | |
| GeneFamily | Cytochrome P450 family 4 | 8.79e-03 | 36 | 71 | 2 | 1003 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.08e-02 | 40 | 71 | 2 | 321 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 5.56e-06 | 117 | 99 | 6 | M39300 | |
| Coexpression | GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN | 9.78e-06 | 196 | 99 | 7 | M8171 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN | 1.07e-05 | 465 | 99 | 10 | M9192 | |
| Coexpression | GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_UP | 1.08e-05 | 199 | 99 | 7 | M7652 | |
| Coexpression | DE_YY1_TARGETS_DN | 2.77e-05 | 93 | 99 | 5 | M3278 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 6.11e-05 | 261 | 99 | 7 | M1834 | |
| Coexpression | NABA_CORE_MATRISOME | 8.48e-05 | 275 | 99 | 7 | M5884 | |
| Coexpression | GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_UP | 1.05e-04 | 197 | 99 | 6 | M7264 | |
| Coexpression | GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 1.08e-04 | 198 | 99 | 6 | M7200 | |
| Coexpression | GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_DN | 1.11e-04 | 199 | 99 | 6 | M7645 | |
| Coexpression | GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP | 1.11e-04 | 199 | 99 | 6 | M9568 | |
| Coexpression | GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN | 1.11e-04 | 199 | 99 | 6 | M3093 | |
| Coexpression | GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN | 1.14e-04 | 200 | 99 | 6 | M3279 | |
| Coexpression | GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN | 1.14e-04 | 200 | 99 | 6 | M8982 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN | 1.14e-04 | 200 | 99 | 6 | M5167 | |
| Coexpression | GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN | 1.14e-04 | 200 | 99 | 6 | M9586 | |
| Coexpression | GSE42021_TREG_VS_TCONV_PLN_UP | 1.14e-04 | 200 | 99 | 6 | M9572 | |
| Coexpression | GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN | 1.14e-04 | 200 | 99 | 6 | M9570 | |
| Coexpression | GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP | 1.14e-04 | 200 | 99 | 6 | M9030 | |
| Coexpression | FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_1DY_POSITIVE | 1.32e-04 | 129 | 99 | 5 | M41110 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 1.43e-04 | 27 | 99 | 3 | M47994 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 1.63e-04 | 135 | 99 | 5 | M5825 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 1.78e-04 | 29 | 99 | 3 | MM17055 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.61e-08 | 196 | 101 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.83e-07 | 192 | 101 | 7 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 2.83e-07 | 192 | 101 | 7 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 3.49e-07 | 198 | 101 | 7 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.49e-07 | 198 | 101 | 7 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.73e-07 | 200 | 101 | 7 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.73e-07 | 200 | 101 | 7 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.73e-07 | 200 | 101 | 7 | 8a4c210a3130f7baedf15ecbc0f4903b97da0352 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.73e-07 | 200 | 101 | 7 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.17e-06 | 177 | 101 | 6 | 6f6cf93893daac6ae228df36219ee3acf8de8f97 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.38e-06 | 179 | 101 | 6 | 8c9ed247e1c4d655b81ce2f24a9936a7cade718a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.49e-06 | 180 | 101 | 6 | a407376209d80177bf7fc4200219030c83cb5f14 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-06 | 184 | 101 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-06 | 184 | 101 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-06 | 184 | 101 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-stromal_related-T_reticular|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.34e-06 | 187 | 101 | 6 | f0c4d93f75615e570e4465fd622e3124189618a1 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-stromal_related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.34e-06 | 187 | 101 | 6 | 3ff57da09ed8394913fb683669d7bff84a936623 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.06e-06 | 192 | 101 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.06e-06 | 192 | 101 | 6 | 11867f30f0b420c18cb0b34d3990237aa737a0e8 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-06 | 193 | 101 | 6 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-06 | 193 | 101 | 6 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-06 | 193 | 101 | 6 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.21e-06 | 193 | 101 | 6 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-06 | 193 | 101 | 6 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-06 | 194 | 101 | 6 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.36e-06 | 194 | 101 | 6 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | (1)_Osterolineage_cells-(11)_OLC-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 5.52e-06 | 195 | 101 | 6 | 78978d85273e5463a7f43e4c121e647fa6aba42b | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.52e-06 | 195 | 101 | 6 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-06 | 196 | 101 | 6 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | ILEUM-non-inflamed-(9)_Enteric_neurons|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.69e-06 | 196 | 101 | 6 | 998aa523555ed6bc9c1b5cacbf7ba77c7b218e6b | |
| ToppCell | ILEUM-non-inflamed-(9)_Neuro_cell|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.69e-06 | 196 | 101 | 6 | 2b08cd6730119d5dea0152709ab8de580b66cd3c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-06 | 196 | 101 | 6 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-stromal_related|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.86e-06 | 197 | 101 | 6 | ea9332adf753d7e92f89654320543abb9e6142aa | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-stromal_related-T_reticular|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.03e-06 | 198 | 101 | 6 | 11f21a4a97da10fc6ae604cb627aa3af749d9dff | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.21e-06 | 199 | 101 | 6 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Dcn-Endothelial_Tip.Dcn.Nenf_(Nenf)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.24e-06 | 114 | 101 | 5 | 7be16e7f7b9c9dbd68933ace3b7f8f661bed41a7 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Dcn|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.24e-06 | 114 | 101 | 5 | f4bdfc47418d22a49e0c4a6c3bd0663e15fb53bb | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.39e-06 | 200 | 101 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | 6.39e-06 | 200 | 101 | 6 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 | |
| ToppCell | 15-Airway|15 / Age, Tissue, Lineage and Cell class | 6.39e-06 | 200 | 101 | 6 | ba4b8d5becf81351901c2ecac74ffa28e29586f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.39e-06 | 200 | 101 | 6 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.39e-06 | 200 | 101 | 6 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Hs3st6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.04e-06 | 123 | 101 | 5 | 64a2d7e40d9c948a9ccaf61c465fb2207e0b7ab8 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.51e-05 | 152 | 101 | 5 | 1b2a39ae159e79f1fb18d6d164bd7acab5299fca | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.76e-05 | 155 | 101 | 5 | 8e239470799426ea474a36f57e1b7e0d9365ca5f | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Vwf_(Vwf)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.02e-05 | 84 | 101 | 4 | 39196f7af1a3199ca611acbe7b2e7a76d79c8fdd | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Vwf_(Vwf)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.02e-05 | 84 | 101 | 4 | 79cdb04e91aa119a128f0fef7a09b59a0edf00a0 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Vwf_(Vwf)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.02e-05 | 84 | 101 | 4 | 66fc8327fc9c0f9a135e874ad2056ca414cd5148 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-05 | 168 | 101 | 5 | 3fb79aaa858057c82645a90bd139fc4f096323c7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.17e-05 | 169 | 101 | 5 | a0681317867e31319210a23e56660a53f4529efe | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.17e-05 | 169 | 101 | 5 | 0589f39d8e9468e42d25d30ff70bb7cb8b921628 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.54e-05 | 172 | 101 | 5 | fc092a0631555d79e00ef9890cbd806e15bca2d4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.54e-05 | 172 | 101 | 5 | ac20766d1fd43eab8c3ff5e7418a6b38bebf0bd5 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.54e-05 | 172 | 101 | 5 | 745725bd10c82017d678463b8fef0d2dcf09a8fd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.54e-05 | 172 | 101 | 5 | 3fd1bc4a8ced0bf9e26ca4ce6d83b5b97bbc2556 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.92e-05 | 175 | 101 | 5 | d4827b4dfad07f11cbdd47fbed287af1afb9b1b8 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-05 | 176 | 101 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.06e-05 | 176 | 101 | 5 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 5.20e-05 | 177 | 101 | 5 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.20e-05 | 177 | 101 | 5 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.20e-05 | 177 | 101 | 5 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.34e-05 | 178 | 101 | 5 | cda7695411655bd6d0ba69e5041ca7530a9dad3a | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.63e-05 | 180 | 101 | 5 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.63e-05 | 180 | 101 | 5 | 5861b44acfb8fe92c281c8355bf19c059b3dcd64 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.74e-05 | 92 | 101 | 4 | ed282f0f3da1593bdec5a2b20af5b8f058574167 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.74e-05 | 92 | 101 | 4 | c5f30d58f235f7a72dfe63f58999c4680502576f | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.74e-05 | 92 | 101 | 4 | 27072dbf6819dca41e41267dc250abfaaf175b2f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 182 | 101 | 5 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 182 | 101 | 5 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.25e-05 | 184 | 101 | 5 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.25e-05 | 184 | 101 | 5 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.41e-05 | 185 | 101 | 5 | 87151ab95530e70d61328b336518df58db584acb | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.41e-05 | 185 | 101 | 5 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.41e-05 | 185 | 101 | 5 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.41e-05 | 185 | 101 | 5 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.57e-05 | 186 | 101 | 5 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.57e-05 | 186 | 101 | 5 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 187 | 101 | 5 | f3ef3f5a761f8306edc39bf16e76e44aae6fa7f6 | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 6.74e-05 | 187 | 101 | 5 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 187 | 101 | 5 | 1669df899b1759c338ffce196fe009840123cfcd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-05 | 188 | 101 | 5 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | Control-Endothelial_cells|Control / group, cell type (main and fine annotations) | 6.91e-05 | 188 | 101 | 5 | 3953b08abfea93468fc8d177bdb16ca7c6ffa1ab | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-05 | 189 | 101 | 5 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-05 | 189 | 101 | 5 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-05 | 190 | 101 | 5 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.27e-05 | 190 | 101 | 5 | d072bb285bd34d518b958e7c9ad44739c60b359c | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.27e-05 | 190 | 101 | 5 | 912aa106581d1ed7e147c92f9a367e8e6b04052b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-05 | 190 | 101 | 5 | 5681c211baeed4af82a2bbc13420f6a7b487581c | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 7.27e-05 | 190 | 101 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.45e-05 | 191 | 101 | 5 | 2b73fcd592d16cae8ded5e45c8fbf2d9adc8caad | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.45e-05 | 191 | 101 | 5 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 7.45e-05 | 191 | 101 | 5 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 7.45e-05 | 191 | 101 | 5 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.45e-05 | 191 | 101 | 5 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.45e-05 | 191 | 101 | 5 | 24d75b7e1d6fb9d24aa7844f584ee888a449841f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.45e-05 | 191 | 101 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.45e-05 | 191 | 101 | 5 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-05 | 192 | 101 | 5 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.64e-05 | 192 | 101 | 5 | 52acaecd3703166f5ce3b328aff7c82bd142fee4 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 7.64e-05 | 192 | 101 | 5 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 2.03e-06 | 189 | 101 | 8 | CID000001413 | |
| Drug | ticlopidine | 6.62e-06 | 103 | 101 | 6 | CID000005472 | |
| Drug | Hycanthone [3105-97-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.09e-05 | 188 | 101 | 7 | 5691_DN | |
| Drug | trifluralin | 2.62e-05 | 131 | 101 | 6 | CID000005569 | |
| Drug | Bezafibrate [41859-67-0]; Down 200; 11uM; PC3; HT_HG-U133A | 2.73e-05 | 196 | 101 | 7 | 6653_DN | |
| Drug | Benzydamine hydrochloride [132-69-4]; Up 200; 11.6uM; HL60; HG-U133A | 3.01e-05 | 199 | 101 | 7 | 1552_UP | |
| Drug | Oxybenzone [131-57-7]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 3.01e-05 | 199 | 101 | 7 | 6469_UP | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 3.01e-05 | 199 | 101 | 7 | 3403_DN | |
| Disease | Thromboembolism | 3.39e-07 | 44 | 97 | 5 | HP_0001907 | |
| Disease | osteochondrodysplasia (biomarker_via_orthology) | 1.07e-05 | 2 | 97 | 2 | DOID:2256 (biomarker_via_orthology) | |
| Disease | glucose-6-phosphate isomerase measurement | 3.20e-05 | 3 | 97 | 2 | EFO_0020407 | |
| Disease | nuclear protein MDM1 measurement | 6.39e-05 | 4 | 97 | 2 | EFO_0802822 | |
| Disease | L lactate dehydrogenase measurement | 8.48e-05 | 26 | 97 | 3 | EFO_0004808 | |
| Disease | procollagen C-endopeptidase enhancer 1 measurement | 1.59e-04 | 6 | 97 | 2 | EFO_0801920 | |
| Disease | Opitz GBBB syndrome (implicated_via_orthology) | 1.59e-04 | 6 | 97 | 2 | DOID:0080697 (implicated_via_orthology) | |
| Disease | solute carrier family 22 member 16 measurement | 1.59e-04 | 6 | 97 | 2 | EFO_0802079 | |
| Disease | very low density lipoprotein cholesterol measurement | 2.23e-04 | 260 | 97 | 6 | EFO_0008317 | |
| Disease | body surface area | 2.73e-04 | 643 | 97 | 9 | EFO_0022196 | |
| Disease | cortical thickness | ARRDC4 LAMA1 LRCH1 STAB1 VPS13D MALRD1 SETD5 COL21A1 ADAMTS18 MACF1 PLCH1 MUSK | 2.91e-04 | 1113 | 97 | 12 | EFO_0004840 |
| Disease | Pena-Shokeir syndrome type I | 2.96e-04 | 8 | 97 | 2 | C1276035 | |
| Disease | Weight Gain | 3.64e-04 | 102 | 97 | 4 | C0043094 | |
| Disease | PR segment | 4.73e-04 | 10 | 97 | 2 | EFO_0005095 | |
| Disease | transmembrane glycoprotein NMB measurement | 4.73e-04 | 10 | 97 | 2 | EFO_0008303 | |
| Disease | C-C motif chemokine 4-like measurement | 5.77e-04 | 11 | 97 | 2 | EFO_0021848 | |
| Disease | optic disc size measurement | 5.92e-04 | 205 | 97 | 5 | EFO_0004832 | |
| Disease | platelet measurement | 6.18e-04 | 315 | 97 | 6 | EFO_0005036 | |
| Disease | T-cell surface glycoprotein CD3 epsilon chain measurement | 8.15e-04 | 13 | 97 | 2 | EFO_0802114 | |
| Disease | resting heart rate | 1.50e-03 | 149 | 97 | 4 | EFO_0004351 | |
| Disease | lysophosphatidylcholine 22:6 measurement | 1.58e-03 | 18 | 97 | 2 | EFO_0010365 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 1.95e-03 | 160 | 97 | 4 | DOID:5844 (biomarker_via_orthology) | |
| Disease | coagulation factor measurement | 1.96e-03 | 20 | 97 | 2 | EFO_0004634 | |
| Disease | coagulation factor V measurement | 1.96e-03 | 20 | 97 | 2 | EFO_0008087 | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 2.16e-03 | 21 | 97 | 2 | EFO_0004286, EFO_0004792 | |
| Disease | phosphatidylcholine measurement | 2.50e-03 | 284 | 97 | 5 | EFO_0010226 | |
| Disease | level of Sphingomyelin (d40:2) in blood serum | 2.59e-03 | 23 | 97 | 2 | OBA_2045181 | |
| Disease | diacylglycerol 34:2 measurement | 3.05e-03 | 25 | 97 | 2 | EFO_0010353 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SPLETCLLELEVSPV | 176 | A8MVM7 | |
| PEDCLSEPCTILQLD | 296 | P55345 | |
| PELVLEEGCCEILPA | 231 | Q07092 | |
| LEEATTICLLPPCIS | 871 | P51816 | |
| PTEVCTIISDPTCEI | 421 | Q14956 | |
| CVLLECLLTPENVPS | 2381 | Q96DT5 | |
| LPVCIVEESTCGDIP | 681 | P08603 | |
| TPEVLVRSCLVPCEK | 231 | A6NFU0 | |
| ESCQCEEILEIVILP | 1056 | Q96PN6 | |
| LALCPIVQHPEDTCI | 871 | Q9NR16 | |
| ICSTLILQPCATLDP | 86 | Q5HYR2 | |
| PVTPETICRDVVDLC | 21 | Q13625 | |
| CTSLPRPELQEGCVL | 1031 | Q8TE60 | |
| EDCTSIPAPTILPCR | 531 | Q16671 | |
| PVTPSILDCCIIRVD | 276 | Q8NCT1 | |
| LDGCCLTPSILPDLT | 361 | Q96M43 | |
| ILLDSGPCIVTECIP | 186 | Q8N6M8 | |
| CILNAETLVCVKEPP | 591 | Q32P28 | |
| ELEEPALSCELEQCP | 841 | Q86VD1 | |
| CPAVCPLEELSPDSI | 681 | Q8TDY2 | |
| LDTCPEEVEIKCPLN | 66 | Q9NZR2 | |
| PCLDLIEGSPISICS | 471 | Q96H55 | |
| RSLVLNTEPAECPVC | 271 | Q9BYM8 | |
| VDIDVLPQIICCSEP | 856 | O43491 | |
| SCCEGEEPLIVPEVR | 551 | P98095 | |
| AQPELESEPCCLTVV | 241 | P56645 | |
| VVTSPEELAIPKCCL | 536 | O75564 | |
| SLVRECPGIEPVCVD | 46 | Q7Z4W1 | |
| TVLEQAIPPCRSICE | 101 | Q14332 | |
| PECISLTSLEDPVIL | 426 | Q99550 | |
| VPEITFCEILPCQET | 696 | Q96LU7 | |
| QLATVPKDIPLDCDC | 406 | O94854 | |
| LGVPEADLCSPCDIL | 656 | Q9Y2L9 | |
| ELVEELEAAPCCPLL | 91 | Q96RT7 | |
| LEAAPCCPLLEVGSV | 96 | Q96RT7 | |
| APCRPCSDTEVLLAV | 186 | Q641Q3 | |
| TSPVDLVINCLDCPE | 401 | Q96F86 | |
| DLLECCLQELREPPD | 181 | A6NMN3 | |
| SILERCPEAIVCSPT | 96 | Q49AM1 | |
| CDSPPVLRLVCADTA | 166 | Q9H208 | |
| EFPCSTDECIPSLLL | 1951 | Q5VYJ5 | |
| TDECIPSLLLCDGVP | 1956 | Q5VYJ5 | |
| TVLDQAIPPCRSLCE | 111 | O75084 | |
| VCEEKASAVLPPTCI | 591 | Q14008 | |
| LVVAENEPCEVTCLP | 151 | Q9NSI5 | |
| EISTAPEIINCCLTP | 511 | Q8NF50 | |
| LLLVTDPTCDCSIFP | 1051 | Q7Z3S7 | |
| CCTQDIVLPDGRVIP | 401 | Q9HCS2 | |
| IVCPDLPCQTELSVA | 811 | P12110 | |
| LCEESVCPTRIPVAA | 211 | Q96P44 | |
| APLPTCEAISCEPLE | 376 | P16109 | |
| LPKAEECDTITLNCP | 51 | Q8WWZ3 | |
| LLPAEGCVICDPSVV | 16 | Q8IYV9 | |
| CCTQDIVLPDGRVIP | 401 | Q08477 | |
| LLECLLTTEDIPADC | 2351 | Q9NYC9 | |
| LICPICSGVLEEPVQ | 16 | Q9H4P4 | |
| VCDLPLDCPVQDVTV | 146 | W5XKT8 | |
| LLAPEDVISCCLDLS | 736 | P21817 | |
| CVDCVIPPEGSLLQE | 151 | Q9BT04 | |
| LSTLDVELPPVCCDI | 186 | O95997 | |
| CLPCVPNILVIATES | 316 | Q99567 | |
| IEEPSQCPDCVVSAL | 166 | P08581 | |
| VVCCEDVFLSDPLLP | 76 | Q8TEE9 | |
| PCVREILSDCALPIA | 586 | Q8NBS3 | |
| VPCLLDTSTIPAEEL | 296 | Q7RTN6 | |
| EEVTCPICLELLTEP | 11 | Q9BYJ4 | |
| PICLELLTEPLSLDC | 16 | Q9BYJ4 | |
| LPLSECPCLVGEELK | 2671 | A2VEC9 | |
| PVEESIIIPCEFCGV | 361 | O14545 | |
| LCPEVQDLLEGCELP | 706 | Q9UPR3 | |
| LDGCCLTPSILPDLT | 361 | Q5VWK0 | |
| ASEEPPCIIAVLCEL | 241 | P28749 | |
| SNVPVSCLDVLICPL | 286 | Q9NVN3 | |
| ICLIPPSLEVVADNC | 226 | Q7Z6Z6 | |
| DSEPPLQCLVLICEA | 211 | Q9Y2N7 | |
| PEEEVASLLENCVCP | 1351 | P25391 | |
| CVCDSETGLLLLPLP | 1421 | P58107 | |
| ECPVECPLRITTDPT | 716 | Q9C0A6 | |
| CIREIPDPDSAELLC | 251 | Q9H1Z4 | |
| ASPCCVSQDLEPLTI | 376 | P61812 | |
| EEVTCPICLELLTQP | 11 | Q9C035 | |
| VDPEPFVALCEKTLC | 241 | P04275 | |
| CPQCRVTSELVIPSE | 361 | Q13064 | |
| LEVSPPRCLVLECTH | 506 | Q86WA9 | |
| VCLAAALLTVCEEIP | 151 | Q03426 | |
| LEELEESEQKCPPCL | 621 | Q9Y5Y9 | |
| SELTCPICLELFEDP | 6 | O15344 | |
| ETPECLVGSVPVQCL | 91 | Q9HBX9 | |
| LQCLEESEPPVDRCL | 2171 | Q9NY15 | |
| CSCELLTDAVDLPRP | 331 | O14492 | |
| CPICLDPFVEPVSIE | 16 | P19474 | |
| DEENICESCLSPILP | 786 | P49754 | |
| PFVEVEIIGLPVDCC | 761 | Q4KWH8 | |
| ESSPRPQCVICGEIL | 761 | O95789 | |
| CPICQGTLREPVTID | 16 | Q9UDY6 | |
| SETCGPPLKDILCLV | 86 | Q8NEK5 | |
| HPCEICTPVLRDILQ | 91 | Q6P9A1 | |
| SELTCPICLELFEDP | 26 | Q9UJV3 | |
| VDLFPVLPICVCDLT | 81 | Q6NUS6 | |
| KEVTCPICLELLTEP | 11 | Q8IYM9 | |
| PICLELLTEPLSLDC | 16 | Q8IYM9 | |
| PCGLTESVEVLCLLV | 121 | Q8NHX9 | |
| EEVTCPICLELLTEP | 11 | Q9C030 | |
| PICLELLTEPLSIDC | 16 | Q9C030 | |
| CCPLPARIQEIVVET | 361 | Q5T124 | |
| LPTVVICNLLPCELD | 3181 | Q5THJ4 | |
| VVSPVCRPAAEALLC | 361 | O15146 | |
| CILRCPDTTDPLQSV | 2216 | B2RTY4 |